Home › Funds › Two Sigma Investments › ESPR

Two Sigma Investments position in ESPR

ESPERION THERAPEUTICS INC NE

Latest position (Q2 2026)7.13M sh
Reported value held$22.52M
Portfolio Weight0.02%
First reportedQ4 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q4 2021 342.65K $1.71M New
Q1 2022 139.90K $649.00K Reduce
Q2 2022 382.40K $2.43M Add
Q3 2022 1.07M $7.16M Add
Q4 2022 1.54M $9.58M Add
Q1 2023 1.06M $1.69M Reduce
Q2 2023 1.18M $1.64M Add
Q3 2023 1.46M $1.43M Add
Q4 2023 2.33M $6.98M Add
Q1 2024 3.98M $10.65M Add
Q2 2024 4.07M $9.05M Add
Q3 2024 3.63M $5.98M Reduce
Q4 2024 3.54M $7.79M Reduce
Q1 2025 2.73M $3.93M Reduce
Q2 2025 1.83M $1.80M Reduce
Q3 2025 2.24M $5.93M Add
Q4 2025 4.74M $17.55M Add
Q1 2026 9.46M $25.92M Add
Q2 2026 7.13M $22.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ESPR

All ESPR fund holders →